MDT
Medtronic plc
Price performance
Sep 18, 2026About
Company activity
27 events| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 3d | MDT | 8-K | Medtronic Corrects Prospectus for Exchange Offer | — | — | — |
| 09/01 | MDT | 8-K | Medtronic Reports Strong Q1 FY27 Results and Raises Guidance | — | — | — |
| 06/03 | MDT | 8-K | Medtronic Reports Highest Annual Revenue Growth in 10 Years and Increases Dividend | — | — | — |
| 05/18 | MDT | 8-K | Medtronic Announces Leadership Change in Neuroscience Portfolio | — | — | — |
| 04/24 | MDT | 8-K | Medtronic Discloses Unauthorized Access to IT Systems | — | — | — |
| 03/24 | MDT | 8-K | FDA Clears MiniMed Flex Insulin Pump, Impacting Medtronic's Q4 Guidance | — | — | — |
| 02/17 | MDT | 8-K | Medtronic Reports Strong Q3 FY2026 Results with 8.7% Revenue Growth | — | — | — |
| 11/18/25 | MDT | 8-K | Medtronic Reports Strong Q2 FY26 Financial Results and Raises Guidance | — | — | — |
| 11/03/25 | MDT | 8-K | Medtronic plc Announces Retirement of Executive Vice President | — | — | — |
| 10/21/25 | MDT | 8-K | Medtronic Approve Shareholder Proposals at Annual General Meeting | — | — | — |
| 09/29/25 | MDT | 8-K | Medtronic PLC Announces Issuance of Senior Notes and Redemption of Outstanding Notes | — | — | — |
| 09/16/25 | MDT | 8-K | Medtronic Announces Pricing of Offering and Redemption of Senior Notes | — | — | — |
| 08/19/25 | MDT | 8-K | Medtronic Reports FY26 Q1 Financial Results and New Board Appointments | — | — | — |
| 06/23/25 | MDT | 8-K | Medtronic Appoints Dr. Joon Lee to Board of Directors | — | — | — |
| 05/21/25 | MDT | 8-K | Medtronic Reports Fiscal Year 2025 Results and Announces Leadership Transition | — | — | — |
| 03/17/25 | MDT | 8-K | Medtronic Announces Transition of Principal Accounting Officer | — | — | — |
| 02/18/25 | MDT | 8-K | Medtronic reports Q3 FY2025 financial results with organic revenue growth and earnings beat | — | — | — |
| 01/21/25 | MDT | 8-K | Medtronic Appoints Thierry Pieton as New CFO | — | — | — |
| 11/19/24 | MDT | 8-K | Medtronic Announces Second Quarter Fiscal Year 2025 Financial Results | — | — | — |
| 10/21/24 | MDT | 8-K | Medtronic Shareholders Elect Directors and Approve Proposals at 2024 AGM | — | — | — |
| 08/20/24 | MDT | 8-K | Medtronic Reports Strong Q1 FY25 Financial Results | — | — | — |
| 08/16/24 | MDT | 8-K | Compensation Approval for Interim CFO | — | — | — |
| 06/26/24 | MDT | 8-K | Medtronic CFO Resignation and Interim CFO Appointment Announced | — | — | — |
| 06/04/24 | MDT | 8-K | Medtronic Announces Retirement of EVP and President, Global Regions | — | — | — |
| 06/03/24 | MDT | 8-K | Medtronic Announces €3 Billion Notes Offering | — | — | — |
| 05/23/24 | MDT | 8-K | Medtronic plc Announces Fiscal Year 2024 Financial Results | — | — | — |
| 02/20/24 | MDT | 8-K | Medtronic Announces Executive Departure Due to Business Restructuring | — | — | — |
MDT filing record
Medtronic plc (MDT): 27 8-K filings summarized, the most recent on Sep 17, 2026.
What the 8-K filings said
- Sep 17, 2026 · low impact
On September 17, 2026, Medtronic plc filed an 8-K to correct a typographical error in the prospectus related to the Exchange Offer. The error was in the description of guaranteed delivery procedures, which has been revised to clarify the expiration time for a notice of guaranteed delivery. The corrected information is…
Medtronic Corrects Prospectus for Exchange Offer - Sep 1, 2026 · high impact
Medtronic plc announced its first quarter fiscal year 2027 financial results, reporting a 13.7% increase in revenue to $9.8 billion, both as reported and organic. The company reported GAAP diluted EPS of $1.14 and non-GAAP diluted EPS of $1.45, ahead of guidance. Medtronic raised its FY27 organic revenue growth…
Medtronic Reports Strong Q1 FY27 Results and Raises Guidance - Jun 3, 2026 · medium impact
Medtronic plc announced its fourth quarter and full year fiscal 2026 financial results, reporting the highest annual revenue growth in 10 years. The company achieved full year revenue of $36.4 billion, an 8.4% increase as reported and 5.8% organic. Non-GAAP diluted EPS for the full year was $5.53, up 0.7%. The company…
Medtronic Reports Highest Annual Revenue Growth in 10 Years and Increases Dividend - May 18, 2026 · high impact
Medtronic plc announced on May 18, 2026, that Brett Wall will be departing from his position as Executive Vice President and President, Neuroscience Portfolio, effective June 1, 2026. Dr. Kweli Thompson, currently Senior Vice President and President, Cardiac Rhythm Management, will assume the role. Mr. Wall will…
Medtronic Announces Leadership Change in Neuroscience Portfolio - Apr 24, 2026 · high impact
On April 24, 2026, Medtronic plc announced that an unauthorized third party had accessed data in certain of the Company's information technology systems. The company promptly took steps to contain the incident, activated its incident response protocols, and engaged leading external cybersecurity experts to support its…
Medtronic Discloses Unauthorized Access to IT Systems
SEC filings in the last five years
- 44 Form 8-K
- 14 Form 10-Q
- 4 Form 10-K
- 1 Form 8-K/A